AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (1.3 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Comment | Open Access

Embracing human relevance: The FDA’s historic move beyond animal testing mandates

Caihong Liu1,§Liangbin Zhou2,§Cheng Jiang1Rocky S.Tuan2Zhong Alan Li2 ( )Chen-zhong Li1( )
Department of Biomedical Engineering, School of Medicine, The Chinese University of Hong Kong (Shenzhen), Shenzhen 518172, China
Department of Biomedical Engineering, Faculty of Engineering, The Chinese University of Hong Kong, Hong Kong SAR, China

§These authors contribute equally to this work.

Show Author Information

References

【1】
【1】
 
 
Cell Organoid
Article number: 9410013

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Liu C, Zhou L, Jiang C, et al. Embracing human relevance: The FDA’s historic move beyond animal testing mandates. Cell Organoid, 2025, 1(2): 9410013. https://doi.org/10.26599/CO.2025.9410013

4192

Views

348

Downloads

7

Crossref

Accepted: 08 May 2025
Published: 26 May 2025
© The Author(s) 2025. Published by Tsinghua University Press

The articles published in this open access journal are distributed under the termsof the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, distribution andreproduction in any medium, provided the original work is properly cited.